National Institutes of Health: all 11,571 studies

Page 101 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Phase II Randomized Study of Tin Mesoporphyrin for Neonatal HyperbilirubinemiaCompletedNCT00004381Phase 2
• Phase II Study of Recombinant Relaxin for Progressive Systemic SclerosisCompletedNCT00004380Phase 2
• Stem Cell Transplantation (SCT) for Genetic DiseasesCompletedNCT00004378Not applicable
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity DisorderCompletedNCT00004376Phase 3
• Ultraviolet Light Therapy for Systemic Lupus ErythematosusStatus unknownNCT00004375Phase 2
• Study of Systemic Amyloidosis Presentation and PrognosisStatus unknownNCT00004374
• Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With AnxietyCompletedNCT00004373Phase 2
• Phase I Study of Colchicine Therapy in Childhood Hepatic CirrhosisStatus unknownNCT00004368Phase 1
• Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without AgoraphobiaCompletedNCT00004367Not applicable
• Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular DysfunctionCompletedNCT00004366Not applicable
• Study of Pituitary Size and Function in Familial Dwarfism of SindhCompletedNCT00004365
• Study of Novel Types of Familial Diabetes InsipidusStatus unknownNCT00004364
• Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes InsipidusCompletedNCT00004363
• Study of the Relationship Between Calcium Levels and Intact Parathyroid Hormone (iPTH) in Adults With Repaired or Palliated Conotruncal Cardiac DefectsCompletedNCT00004361
• Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes InsipidusCompletedNCT00004360
• Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa AcquisitaCompletedNCT00004359Phase 2
• Phase II Study of Calcitonin for Tumoral CalcinosisCompletedNCT00004358Phase 2
• Study of Homocysteine Metabolism in HomocystinuriaCompletedNCT00004356
• Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable AldosteronismCompletedNCT00004354
• Study of the Metabolism of Pyruvate and Related Problems in Patients With Lactic AcidemiaCompletedNCT00004353
• Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion SyndromesCompletedNCT00004351
• Evaluation of Fanconi Syndrome and CystinosisCompletedNCT00004350
• Study of Protein Translocation in Patients With Beta-Oxidation DisordersCompletedNCT00004348
• Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz SyndromeStatus unknownNCT00004347Phase 2
• Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous XanthomatosisStatus unknownNCT00004346Phase 2
• Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher SyndromeTerminatedNCT00004345
• Purification of Testis-Stimulating Factor in Precocious PubertyCompletedNCT00004344
• Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's SyndromeStatus unknownNCT00004343
• International Registry for Severe Chronic NeutropeniaStatus unknownNCT00004342
• Study of Genetic and Molecular Defects in Primary Immunodeficiency DisordersStatus unknownNCT00004341
• Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance DialysisCompletedNCT00004340Phase 2
• Study of Tetrathiomolybdate in Patients With Wilson DiseaseCompletedNCT00004339Phase 3
• Study of Zinc for Wilson DiseaseCompletedNCT00004338Phase 4
• Pilot Study of Familial Nonsyndromal Mondini DysplasiaCompletedNCT00004336
• Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual CycleCompletedNCT00004335
• Study of Depression, Peptides, and Steroids in Cushing's SyndromeStatus unknownNCT00004334
• Phase II Study of the Enzyme Inhibitor NTBC for Tyrosinemia Type ICompletedNCT00004333Phase 2
• Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in AcromegalyCompletedNCT00004332
• Studies in Porphyria I: Characterization of Enzyme DefectsStatus unknownNCT00004331
• Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic AttacksCompletedNCT00004330Not applicable
• Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional LipoatrophyCompletedNCT00004329
• Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type ICompletedNCT00004328Phase 2
• Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile EctasiaCompletedNCT00004327Phase 2
• Hippocampal Complex Volume and Memory Dysfunction in Cushing's SyndromeCompletedNCT00004326
• Study of the Neurobiology of Tourette Syndrome and Related DisordersCompletedNCT00004325
• Developmental Phenomenology of Obsessive Compulsive Disorder and Tourette Syndrome in Children and AdolescentsCompletedNCT00004324
• Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic AnemiaCompletedNCT00004323Phase 2
• Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar VestibulitisCompletedNCT00004316Phase 1/2
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver DiseaseStatus unknownNCT00004315Phase 2
• Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan DiseaseCompletedNCT00004314Phase 2
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone Replacement for Primary Adrenal InsufficiencyCompletedNCT00004313Phase 3
• Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic CystinosisCompletedNCT00004312
• Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans SyndromeCompletedNCT00004311Phase 2
• Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive DisorderStatus unknownNCT00004310Phase 2
• Study of Treatment and Metabolism in Patients With Urea Cycle DisordersStatus unknownNCT00004307Phase 1
• Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)CompletedNCT00004306
• Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA GlomerulonephritisCompletedNCT00004305
• Phase II Study of Stereotypes and Mental Retardation: Neurobiological BasisSuspendedNCT00004300Phase 2
• Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status EpilepticusCompletedNCT00004297Phase 3
• Multicenter Study of Nontuberculous Mycobacteria in Cystic Fibrosis PatientsCompletedNCT00004296
• Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher DiseaseCompletedNCT00004294Phase 1
• Phase II Study of Glucocerebrosidase in Patients With Gaucher DiseaseStatus unknownNCT00004293Phase 2
• Phase II Pilot Study of Olsalazine for Ankylosing SpondylitisCompletedNCT00004288Phase 2
• Phase I Study of the Third Generation Adenovirus H5.001CBCFTR in Patients With Cystic FibrosisCompletedNCT00004287Phase 1
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
• Effect of Dialysis Dose and Membrane Flux in Maintenance HemodialysisCompletedNCT00004285Not applicable
• Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive HypercalciuriaCompletedNCT00004284Phase 3
• Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus InfectionCompletedNCT00004278Phase 3
• Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV InfectionsCompletedNCT00004276Phase 2
• Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's SyndromeCompletedNCT00004275Phase 2
• Effect of Estrogen on Mental and Social Functioning in Girls With Turner's SyndromeCompletedNCT00004274Not applicable
• Phase II Study of Midodrine for Neurogenic Orthostatic HypotensionCompletedNCT00004268Phase 2
• Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 DiabetesCompletedNCT00004266Phase 3
• Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma MultiformeCompletedNCT00004262Phase 1
• Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant MelanomaCompletedNCT00004244Phase 1
• Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004242Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
• Endostatin in Treating Patients With Advanced Solid TumorsCompletedNCT00004229Phase 1
• Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon CancerCompletedNCT00004210Not applicable
• Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerCompletedNCT00004189Phase 1
• Vaccine Therapy in Treating Patients With Unresectable Metastatic MelanomaCompletedNCT00004148Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00004101Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxStatus unknownNCT00004094Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid CancerCompletedNCT00004089Phase 2
• Gene Therapy in Treating Patients With Recurrent or Progressive Brain TumorsCompletedNCT00004080Phase 1
• Sarcosinamide Nitrosourea in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00004079Phase 1
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Gene Therapy Plus Chemotherapy in Treating Patients With Breast CancerCompletedNCT00004038Phase 1
• Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian CancerCompletedNCT00004032Phase 1
• Vaccine Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00004029Phase 1
• Carmustine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004028Phase 1
• 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00003997Phase 1
• Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2CompletedNCT00003995Phase 2
• Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00003993Phase 1
• Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2CompletedNCT00003992Phase 2
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Kidney CancerCompletedNCT00003968Phase 2
• Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaCompletedNCT00003934Phase 3
• Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003909Phase 1

← National Institutes of Health overview and focus areas